Min Li | DNA Sequencing | Best Researcher Award

Dr. Min Li | DNA Sequencing | Best Researcher Award

Guangxi University | China

Author Profile

Scopus

Orcid ID

🏫 EARLY ACADEMIC PURSUITS

Min Li embarked on her academic journey with a Bachelor’s degree in Biotechnology from Southwest Forestry University (2008–2009). Demonstrating an early interest in plant biology, she pursued her Ph.D. in Crop Genetics and Breeding at Guangxi University (2015–2020), where she developed expertise in cotton genetics and CMS mechanisms. Her doctoral research laid the foundation for her impactful career in plant genomics.

💼 PROFESSIONAL ENDEAVORS

Min Li is currently a Postdoctoral Fellow at Guangxi University. During her postdoctoral fellowship, she has delved deeper into the molecular biology of CMS, focusing on its application in cotton breeding. Her collaborative work and independent projects have solidified her role as a key contributor in the field of plant genetics.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DNA SEQUENCING

Min Li’s research is centered on:

  1. Molecular Mechanisms of Cytoplasmic Male Sterility (CMS):
    She explores the genetic basis of CMS in cotton (Gossypium hirsutum L.), identifying and characterizing CMS-associated genes critical for hybrid seed production.
  2. Functional Validation of Genes:
    Her work extends to validating the roles of CMS genes in male sterility and fertility restoration, offering practical insights for breeding programs.
  3. Hybrid Cotton Breeding:
    Min Li’s contributions aim to enhance the efficiency and sustainability of hybrid seed production, addressing challenges in global agriculture.

🌍 IMPACT AND INFLUENCE

Min Li’s research is instrumental in understanding CMS at a molecular level, contributing to breakthroughs in hybrid breeding technologies. Her work supports the development of high-yielding, stress-resistant cotton varieties, significantly impacting agricultural productivity and sustainability.

📚 ACADEMIC CITES

Min Li has authored several influential publications in the field of plant genetics. Her works are widely cited, reflecting her contributions to advancing CMS research. She has also collaborated on major projects funded by prominent organizations, adding to her academic footprint.

🏆 RESEARCH GRANTS AND FUNDING

Min Li has successfully secured and participated in various prestigious research projects, including:

  • Principal Investigator:
    • Guangxi Natural Science Foundation of China, 2022GXNSFBA035451 (2022–2025).
    • China Postdoctoral Science Foundation, 2021MD703812 (2021–2023).
  • Collaborator:
    • National Natural Science Foundation of China, Regional Science Fund Project (2021–2024).
    • Guangxi Natural Science Foundation of China, 2017GXNSFA198023 (2017–2020).

🧬 LEGACY AND FUTURE CONTRIBUTIONS

Min Li envisions leveraging her expertise to further explore genetic mechanisms in plants, with a focus on translating molecular insights into practical breeding applications. Her research has the potential to revolutionize hybrid seed technologies, making agriculture more efficient and resilient to environmental challenges. Her legacy lies in her dedication to understanding and addressing complex genetic challenges, and she continues to inspire the next generation of researchers in plant genetics and genomics.

🌟 A VISIONARY IN COTTON GENETICS

Min Li’s career exemplifies the profound impact of innovative research in genetics and genomics. Through her work, she has positioned herself as a trailblazer in unraveling the complexities of plant molecular biology, paving the way for transformative advancements in global agriculture.

📑 NOTABLE PUBLICATIONS 

"Impact of lignin on the starch accumulation, composition, and pasting properties of cassava

  • Authors: Cai, Z. , Li, M. , Zhang, F. , Ye, W.-T. , Fan, X.-W.
  • Journal: LWT
  • Year: 2023

"LC–MS/MS-based metabolomics approach revealed novel phytocompounds from sugarcane rind with promising pharmacological value

  • Authors: Rao, M.J. , Duan, M. , Wei, X. , Hu, L. , Wang, L.
  • Journal: Journal of the Science of Food and Agriculture
  • Year: 2022

"Sugarcane Rind Secondary Metabolites and Their Antioxidant Activities in Eleven Cultivated Sugarcane Varieties

  • Authors: Rao, M.J. , Duan, M. , Yang, M. , Li, M. , Wang, L.
  • Journal: Sugar Tech
  • Year: 2022

"Genome-Wide Transcriptomic Analysis Reveals the Gene Regulatory Network Controlled by SRL1 in Regulating Rice Leaf Rolling

  • Authors: Li, M. , Li, X. , Zhu, L. , Jin, J. , Wang, J.
  • Journal: Journal of Plant Growth Regulation
  • Year: 2022

"Transcriptomic and Widely Targeted Metabolomic Approach Identified Diverse Group of Bioactive Compounds, Antiradical Activities, and Their Associated Genes in Six Sugarcane Varieties

  • Authors: Rao, M.J. , Duan, M. , Wang, J. , Hu, L. , Wang, L.
  • Journal: Antioxidants
  • Year: 2022

Haifeng Shi | Infectious Diseases | Excellence in Research 

Dr. Haifeng Shi | Infectious Diseases | Excellence in Research 

Jiangsu University | China

Author Profile

Scopus

Dr. Shi Haifeng: Pioneer in Metal Toxicology and Cell Damage Detection 🔬

EARLY ACADEMIC PURSUITS 🎓

Dr. Shi Haifeng's academic journey began with a Bachelor’s degree in Biochemistry from Nanjing University in 1998. His passion for biochemistry led him to pursue a Ph.D. at the Hong Kong University of Science and Technology, where he studied under the mentorship of Professor Hong Xue, earning his doctorate in 2002. This foundation set the stage for his future groundbreaking research in the field of metal ion metabolism and toxicity.

PROFESSIONAL ENDEAVORS 🧑‍🔬

After obtaining his Ph.D., Dr. Shi continued his work at the Hong Kong University of Science and Technology as a Research Associate from 2002 to 2004, further honing his research skills. He then embarked on an international academic experience as a Visiting Scholar at the National Institutes of Health (NIH), specifically within the Liver Diseases Branch of the NIDDK, from 2004 to 2009. His time at the NIH allowed him to deepen his expertise in molecular toxicology and disease mechanisms.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🧪

Dr. Shi’s research is focused on the metabolism and biological toxicity of metal ions such as iron, copper, and cadmium. His work is crucial in understanding how these metals impact biological systems, particularly in the context of heavy metal nephropathy. Additionally, his innovative work on the use of cell-free circulating cfDNA in blood as a biomarker for tissue cell damage has broad applications in medical diagnostics and environmental toxicology. His experimental models, which include yeast, silkworms, and mice, have helped to clarify the toxicological effects of metals at both molecular and systemic levels.

IMPACT AND INFLUENCE 🌍

Dr. Shi’s contributions to the scientific community are widely recognized. He has published over 70 research papers in prestigious international journals. One of his papers was recommended by Professor Alan Parrish from the University of Missouri-Columbia and listed by "Faculty Opinions" (formerly F1000Prime), a distinction reserved for papers with significant impact on their field. Another of his publications has been selected as an ESI Highly Cited Paper, placing him among the top 1% of researchers in his field.

ACADEMIC CITATIONS 📚

Dr. Shi’s work is highly cited, and his recognition as an ESI Highly Cited Researcher underscores his influence on the global scientific community. His papers continue to guide researchers in the fields of toxicology, nephropathy, and medical diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Dr. Shi Haifeng’s legacy lies in his groundbreaking work on the biological effects of heavy metals and his innovative use of cfDNA in disease detection. As a leader in his field, his future contributions are expected to expand the frontiers of biochemistry and toxicology, with significant implications for both environmental health and clinical medicine. His continued dedication to both research and education ensures that he will remain an influential figure in his field for years to come.

NOTABLE PUBLICATIONS 📑

"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy" 

  • Authors: Guo, C. , Ruan, J. , Li, Z. , Gu, J. , Shi, H.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024

"From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death" 

  • Authors: Gu, J. , Guo, C. , Ruan, J. , Gong, X. , Shi, H.
  • Journal: Apoptosis
  • Year: 2024

"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release" 

  • Authors: Xu, L. , He, L. , Li, Y. , Shi, H. , Zhu, C.
  • Journal: Biomedical Materials (Bristol)
  • Year: 2024

"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers" 

  • Authors: Xu, L. , Li, Y. , Cai, T. , Chu, Z. , Shen, X
  • Journal: Macromolecular Research
  • Year: 2024

"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation" 

  • Authors: Cao, C. , Yuan, L. , Wang, Y. , Shi, H. , Jiang, T.
  • Journal: Frontiers in Immunology
  • Year: 2024

Yulian Ding | Molecular Basis of Genetic Disease | Best Researcher Award

Dr. Yulian Ding | Molecular Basis of Genetic Disease | Best Researcher Award

Shenzhen Institute of Advanced Technology | China

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 YULIAN DING, PH.D. – PIONEER IN BIOMEDICAL ENGINEERING AND MACHINE LEARNING

EARLY ACADEMIC PURSUITS🎓

Yulian Ding embarked on her academic journey with a Bachelor of Science in Computer Science from Luoyang Normal University (2010-2014). Her passion for data science and bioinformatics was further solidified during her Master's degree in Computer Science at Shaanxi Normal University (2014-2017), where she focused on dynamic protein complex identification and essential protein identification through swarm intelligence optimization. Her research, under the guidance of Dr. Xiujuan Lei, shaped her understanding of computational biology and bioinformatics. In 2018, Yulian took her academic prowess to the next level by pursuing a Ph.D. in Biomedical Engineering at the University of Saskatchewan (2018-2022). Under the supervision of Dr. Fang-Xiang Wu, she developed advanced machine learning models to predict biomolecule-disease associations, working with miRNAs, lncRNAs, and circRNA.

PROFESSIONAL ENDEAVORS🧑‍🔬

Upon completing her Ph.D., Yulian Ding transitioned into various research roles that leveraged her expertise in both machine learning and biomedical engineering. From March 2022 to February 2023, she served as an Assistant Researcher at the Center for High Performance Computing, Shenzhen Institute of Advanced Technology, under the prestigious Chinese Academy of Sciences. Her work there focused on drug design and disease biomarker identification using machine learning techniques, contributing to major advancements in protein-ligand interaction prediction. Concurrently, Yulian completed a Postdoctoral Fellowship at the University of Saskatchewan’s College of Medicine and Division of Biomedical Engineering. She specialized in bio-data analytics, working on clinical data, particularly in identifying cirRNA biomarkers for cancer.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETIC DISEASE🔬

Yulian Ding’s research focuses on biomedical informatics, particularly at the intersection of machine learning and biomolecular interaction. Her key contributions lie in:

  • Developing novel machine learning models for predicting disease-associated biomolecules, including miRNAs, lncRNAs, and circRNA.
  • Drug design and disease biomarker discovery, particularly through the integration of machine learning in protein-ligand interactions.
  • Enhancing the understanding of bio-data analytics in oncology, utilizing vast datasets to identify crucial molecular targets for treatment.

IMPACT AND INFLUENCE🌍

Ding's work has had significant implications in precision medicine, especially in the early detection of diseases through biomarker identification. Her research on biomolecule-disease associations and the use of machine learning for drug discovery has positioned her as a rising leader in the biomedical engineering field. Her collaboration with leading scientists and institutions, including her postdoctoral work, has influenced both academic research and practical applications in biotechnology.

ACADEMIC CITES📚

Yulian Ding has been recognized for her academic excellence through numerous prestigious awards:

  • Dr. Victor A. Pollak and Mirka B. Pollak Scholarship (2021, University of Saskatchewan)
  • Russell (Russ) William Haid Memorial Award (2020, University of Saskatchewan)
  • China’s National Scholarship for Graduate Students (2017)
  • China’s National Second Prize of Lanqiao Cup Software Design Competition (2014)
  • ACM Programming Competition Silver Medal (2014)

Her work has been published in leading academic journals and recognized by international peers in the fields of bioinformatics and computational biology. As a journal reviewer for notable journals like Neurocomputing, Knowledge-Based Systems, and PLOS Computational Biology, she has contributed to shaping future research trends.

LEGACY AND FUTURE CONTRIBUTIONS🔮

Yulian Ding's legacy is deeply intertwined with her pioneering work in biomedical engineering. By harnessing the power of machine learning, she has opened new avenues for disease diagnosis and drug development. Her future endeavors are poised to push the boundaries of biomedical innovation, with a continued focus on applying computational intelligence to solve biomedical challenges. Through ongoing research and collaboration, Yulian will undoubtedly remain at the forefront of biomedical science, contributing to innovations that bridge the gap between computation and medicine.

 FINAL THOUGHTS🏅

Yulian Ding's academic journey, professional achievements, and innovative research establish her as a significant figure in biomedical engineering. Her work continues to make impactful contributions to precision medicine and biomedical informatics, shaping the future of healthcare through cutting-edge machine learning applications.

NOTABLE PUBLICATIONS📑

"MRDPDA: A multi-Laplacian regularized deepFM model for predicting piRNA-disease associations" 

  • Authors: Liu, Y. , Zhang, F. , Ding, Y. , Li, J. , Wu, F.-X.
  • Journal: Cellular and Molecular Medicine
  • Year: 2024

"P4PC: A Portal for Bioinformatics Resources of piRNAs and circRNAs" 

  • Authors: Liu, Y., Li, R., Ding, Y., Hei, X., Wu, F.-X.
  • Journal: Bioinformatics
  • Year: 2024

"Negative sample selection for miRNA-disease association prediction models" 

  • Authors: Ding, Y. , Wang, F. , Zhang, Y. , Wu, F.-X.
  • Journal: Machine Learning Methods for Multi-Omics Data Integration
  • Year: 2023

"Biomarker Identification via a Factorization Machine-Based Neural Network With Binary Pairwise Encoding" 

  • Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
  • Journal: IEEE/ACM Transactions on Computational Biology and Bioinformatics
  • Year: 2023

"MLRDFM: a multi-view Laplacian regularized DeepFM model for predicting miRNA-disease associations" 

  • Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
  • Journal: Briefings in Bioinformatics
  • Year: 2022